
    
      This is a prospective, single-arm, observational study. After the subjects meet the inclusive
      and exclusive criteria, then they will receive albumin-bound paclitaxel treatment. The
      researchers can choose the treatment based on albumin-bound paclitaxel and choose dosage
      according to the patient's condition.
    
  